Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Short term Debt (2017 - 2024)

Organogenesis Holdings has reported Short term Debt over the past 8 years, most recently at $6.0 million for Q3 2024.

  • Quarterly results put Short term Debt at $6.0 million for Q3 2024, up 8.77% from a year ago — trailing twelve months through Sep 2024 was $6.0 million (up 8.77% YoY), and the annual figure for FY2023 was $5.5 million, up 20.89%.
  • Short term Debt for Q3 2024 was $6.0 million at Organogenesis Holdings, up from $5.8 million in the prior quarter.
  • Over the last five years, Short term Debt for ORGO hit a ceiling of $22.5 million in Q2 2021 and a floor of $1.7 million in Q1 2020.
  • Median Short term Debt over the past 5 years was $5.5 million (2023), compared with a mean of $7.1 million.
  • Peak annual rise in Short term Debt hit 912.3% in 2021, while the deepest fall reached 84.06% in 2021.
  • Organogenesis Holdings' Short term Debt stood at $16.7 million in 2020, then tumbled by 84.06% to $2.7 million in 2021, then surged by 70.86% to $4.5 million in 2022, then increased by 20.89% to $5.5 million in 2023, then grew by 8.71% to $6.0 million in 2024.
  • The last three reported values for Short term Debt were $6.0 million (Q3 2024), $5.8 million (Q2 2024), and $5.5 million (Q1 2024) per Business Quant data.